Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Sci Rep ; 9(1): 16621, 2019 11 12.
Artigo em Inglês | MEDLINE | ID: mdl-31719649

RESUMO

Grapefruit juice (GFJ) and naringin when consumed previously or together with medications may alter their bioavailavility and consequently the clinical effect. Ifosfamide (IF) is an antitumoral agent prescribed against various types of cancer. Nevertheless, there is no information regarding its interaction with the ingestion of GFJ or naringin. The aims of the present report were validating a method for the quantitation of IF in the plasma of mouse, and determine if mice pretreated with GFJ or naringin may modify the IF pharmacokinetics. Our HPLC results to quantify IF showed adequate intra and inter-day precision (RSD < 15%) and accuracy (RE < 15%) indicating reliability. Also, the administration of GFJ or naringin increased Cmax of IF 22.9% and 17.8%, respectively, and decreased Tmax of IF 19.2 and 53.8%, respectively. The concentration of IF was higher when GFJ (71.35 ± 3.5 µg/mL) was administered with respect to that obtained in the combination naringin with IF (64.12 ± µg/mL); however, the time required to reach such concentration was significantly lower when naringin was administered (p < 0.5). We concluded that pre-administering GFJ and naringin to mice increased the Tmax and decreased the Cmax of IF.


Assuntos
Antineoplásicos/farmacocinética , Citrus paradisi/efeitos adversos , Flavanonas/efeitos adversos , Interações Alimento-Droga , Sucos de Frutas e Vegetais/efeitos adversos , Ifosfamida/farmacocinética , Animais , Antineoplásicos/administração & dosagem , Antineoplásicos/sangue , Cromatografia Líquida de Alta Pressão , Interações Medicamentosas , Ifosfamida/administração & dosagem , Ifosfamida/sangue , Masculino , Camundongos , Camundongos Endogâmicos ICR
2.
Clin Interv Aging ; 4: 343-50, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19750234

RESUMO

INTRODUCTION: Six out of every 10 elderly persons live in developing countries. OBJECTIVE: To analyze and assess the drug prescription patterns and errors in elderly outpatients attending public health care centers in Mexico City, Mexico. MATERIALS AND METHODS: A descriptive and retrospective study was conducted in 2007. Fourteen hundred prescriptions were analyzed. Prescriptions of ambulatory adults aged >70 years who were residents of Mexico City for at least two years were included. Prescription errors were divided into two groups: (1) administrative and legal, and (2) pharmacotherapeutic. In group 2, we analyzed drug dose strength, administration route, frequency of drug administration, treatment length, potential drug-drug interactions, and contraindications. Variables were classified as correct or incorrect based on clinical literature. Variables for each drug were dichotomized as correct (0) or incorrect (1). A Prescription Index (PI) was calculated by considering each drug on the prescription. SPSS statistical software was used to process the collected data (95% confidence interval; p <0.05). RESULTS: The drug prescription pattern in elderly outpatients shows that 12 drugs account for 70.72% (2880) of prescribed drugs. The most prescribed drugs presented potential pharmacotherapeutic errors (as defined in the present study). Acetylsalicylic acid-captopril was the most common potential interaction (not clinically assessed). Potential prescription error was high (53% of total prescriptions). Most of the prescription errors were due to omissions of dosage, administration route, and length of treatment and may potentially cause harm to the elderly outpatients. CONCLUSIONS: A high number of potential prescription errors were found, mainly due to omissions. The drug prescription pattern of the study population is mainly constituted by 12 drugs. The results indicate that prescription quality depends on the number of prescribed drugs per prescription (p < 0.000).


Assuntos
Centros Comunitários de Saúde , Prescrições de Medicamentos , Erros de Medicação/estatística & dados numéricos , Saúde Pública , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Modelos Logísticos , Masculino , México , Pacientes Ambulatoriais , Padrões de Prática Médica , Estudos Retrospectivos , População Urbana
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA